Documentation hub
Documentation
Everything documented about ITISYOU today, in one place. There is no API reference, no CLI, and no user guide yet — because those things don't exist yet. What's listed as available below is real and current.
Current documentation
Every module of the browser — responsibility, interfaces, status, and security boundary — plus the ADR-001 engine decision.
Why AI is off by default, what 'disabled interfaces only' means concretely, and the rules any future AI capability must obey.
Sandbox preservation, the three-layer privilege separation, and the deny-by-default permission policy.
Separate local datasets, zero telemetry endpoints, and how this website itself behaves (no analytics, no cookies).
Live phase and milestone data rendered from the project's own status file, plus the JSON status API.
The running narrative: decisions, constraints, problems, and lessons — generated from the project's STORY.md.
A sourced, dated capability table across ten browsers — with ITISYOU's column honestly marked in-development.
Direct answers about project status, downloads, AI, Tor, telemetry, and the engine.
Status API
The project's live status document — the same data behind the progress page — is served as JSON with CORS enabled for GET requests, so you can track development from your own tools.
GET /api/status
{
"schemaVersion": 1,
"product": "ITISYOU Browser",
"productVersion": "0.1.0-dev",
"currentPhase": 1,
"releaseStatus": "development",
"ai": { "state": "disabled", "providerCalls": 0 }…
}
Documentation that doesn't exist yet
Listed so you know what's coming — and what's honestly not written today.
Using Tab Mode, workspaces, the command palette, and settings.
Arrives with the first usable builds.
Building ITISYOU from source; the source policy is revisited before release.
Arrives when the source is published.
A real changelog will start at the first shipped version — not before.
Arrives with the first release.
Developer documentation for the extension and skills runtimes, once they exist.
Arrives Phase 2+.